Roadshow recap: 2013 Medical device innovations (NYC & Boston)

cover(Posted by Aliza Auslander)

On January 28th and 29th, we hosted, together with the New England-Israel Business Council, a delegation of 8 Israeli medical device start-ups at two successful events in New York City and Boston, part of a 5-city roadshow across the country.  The events were a joint effort of Invest in Israel, the Foreign Trade Administration and the Technological Incubators Program of the Chief Scientist’s Office.
Both programs were attended by 80+ investors, strategic partners, and industry professionals, and featured presentations by each of the Israeli CEOs, educational seminars by keynote speakers, roundtable discussions, and Q&A sessions led by panels of industry experts.

full room
In New York, the Q&A panel included industry notables Ilana Odess, co-founder and Managing Partner, VBIOTA; Noah Kroloff, Partner, NGN Capital; Dr. Giora Weisz, Director of Clinical Cardiovascular Research, New York Presbyterian Hospital/Columbia Medical Center; David Frank, Managing Director, MedX Associates; Ken Abramowitz, Managing Partner, NGN Capital; Dr. Yuval Binur, Managing Partner, Orchestra Medical Ventures; and Samuel Feigin, Partner, Chair Israel Business, Nixon Peabody.  The New York program also included two MCRA seminars, one on reimbursement by expert Timothy Hunter, VP, Health Economics, Reimbursement & Public Policy, and one on clinical and regulatory issues, by Glenn Stiegman, VP, Clinical and Regulatory Affairs.

CLICK HERE for photos of the medical device conference in NYC


Our Boston program was coordinated with the support of the New England Israel Business Council, and consisted of a full day of exposure to the Boston-area medical device community.

During the morning session in Boston, we organized an exclusive roundtable discussion, led by senior executives Dennis Crowley, VP Corporate Development & Licensing at Covidien; Dr. Andrew Jay, Fund Head for Medical Solutions Fund, Siemens Venture Capital, and Jake Giannotti, Senior Director Corporate Mergers & Acquisitions Healthcare Sector at Philips Healthcare.  During this session, the Israeli companies had the chance to present their solutions to the corporates and learn about what qualifications these three companies look for in investment and partnership opportunities. 
The two events also incorporated time for 40 prearranged one-on-one meetings between the Israeli companies and various investors and strategic partners.  We have already received feedback that many of these meetings were quite positive and had great potential for follow up activities.

CLICK HERE for photos of the medical device conference in BOSTON

List of participating Israeli companies:

  • ArchMedical – developers of an innovative approach for performing lateraIMG_1486l tissue sampling that allows for access of many hard-to-reach tissue targets.
  • BiFlow Medical – developers of the Nitino stent.  The Nitino stent is deployed in the secondary artery of the heart, which allows blood flow from a main artery to a secondary artery.
  • Cath Med – developers of a proprietary trans-cervical CVS catheter which eliminates the need for multiple catheters and re-insertions.
  • Chi2Gel – developers of an injectable hydrogel for pain relief in painful orthopedic/rheumatologic diseases such as osteoarthritis and spine disc disease.
  • Coeruleus – innovative pharmaceutical solutions for the treatment of a wide range of disorders.
  • DiACardio – a set of tools which enables cardiologists using Echo to automatically evaluate heart failure signs.
  • Medasense Biometrics – developers of a new objective pain monitoring device offering continuous assessment of pain level for non-communicating patients.
  • Moebius Medical – developers of an intra-articular injectable solution for osteoarthritis.

For photos of the roadshow, please visit our FACEBOOK PAGE.  For more information about medical device innovation, biomed R&D or life science technology from Israel, please contact Rebecca at the Israel Economic Mission in NYC.